RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000129.xml
Kardiologie up2date 2009; 5(3): 259-271
DOI: 10.1055/s-0029-1215271
DOI: 10.1055/s-0029-1215271
Bildgebung und interventionelle Techniken
© Georg Thieme Verlag KG Stuttgart · New York
Diagnostik der Kardiomyopathien mittels der kardialen Magnetresonanztomografie
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
15. Oktober 2009 (online)
![](https://www.thieme-connect.de/media/kardiologie-u2d/200903/lookinside/thumbnails/10.1055-s-0029-1215271-1.jpg)
Abstract
Cardiac magnetic resonance imaging (CMR) is a diagnostic multi-modality tool. It provides valuable information about myocardial function, morphology and tissue characterization. Cardiomyopathies are diseases of the heart with a broad spectrum of morphological and functional alterations. CMR offers differential diagnosis as well as prognostic information in these diseases and thus can guide specific treatment.
Literatur
- 1 Aherne T, Tscholakaff D, Finkbeiner W. et al . Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression. Circulation. 1986; 74 145-156
- 2 Kim R J, Fieno D S, Parrish T B. et al . Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100 1992-2002
- 3 Marholdt H, Goedecke C, Wagner A. et al . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004; 109 1250-1258
- 4 Vogelsberg H, Marholdt H, Deluigi C C. et al . Cardiovascular magnetic resonance in clinically suspected cardiac amyoloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008; 51 1022-1030
- 5 McCrohon J A, Moon J C, Prasad S K. et al . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation. 2003; 108 54-59
- 6 Soriano , CJ , Ridocci F, Estornell J. et al . Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience. Int J Cardiol. 2007; 116 167-173
- 7 Zimmermann O, Grebe O, Merkle N. et al . Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail. 2006; 8 162-166
- 8 Assomull R G, Prasad S K, Lyne J. et al . Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006; 48 1977-1985
- 9 Wu K C, Weiss R G, Thiemann D R. et al . Late gadolinium enhancement by cardiovascular magnetic resonance heralds and adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008; 51 2414-2421
- 10 Hombach V, Merkle N, Torzewski J. et al . Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 2009; nur Online, Zitat durch DOI: DOI: 10.1093/eurheartj/ehp293
- 11 Nazarian S, Bluemke D A, Lardo A C. et al . Magnetic resonance assessment oft he substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005; 112 2821-2825
- 12 Moon J C, Fisher N G, McKenna W J, Pennell D J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart. 2004; 90 645-649
- 13 Rickers C, Wilke N M, Jerosch-Herold M. et al . Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005; 112 855-861
- 14 Moon J C, McKenna W J, McCrohon J A. et al . Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003; 41 1561-1567
- 15 Adabag A S, Maron B J, Appelbaum E. et al . Occurence and frequency of arrythmias in hypertropic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008; 51 1369-1374
- 16 Petersen S E, Jerosch-Herold M, Hudsmith L E. et al . Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007; 115 2418-2425
- 17 Olivotto I, Maron M S, Autore C. et al . Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008; 52 559-566
- 18 Maron M S, Hauser T H, Dubrow E. et al . Right ventricular involvement in hypertrophic cardiomyopathy. Am J Cardiol. 2007; 100 1293-1298
- 19 Abdel-Aty H, Cocker M, Strohm O. et al . Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging. 2008; 28 242-245
- 20 Hombach V, Merkle N, Kestler H A. et al . Characterization of patients with acute chest pain using cardiac magnetic resonance imaging. Clin Res Cardiol. 2008; 97 760-767
- 21 Assomull R G, Lyne J C, Keenan N. et al . The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J. 2007; 28 1242-1249
- 22 Marholdt H, Wagner A, Deluigi C C. et al . Presentation patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006; 114 1581-1590
- 23 Lieberman E B, Hutchins G M, Herskowitz A. et al . Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991; 18 1617-1626
- 24 Abdel-Aty H, Boyé P, Zagrosek A. et al . Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005; 45 1815-1822
- 25 Friedrich M G, Sechtem U, Schulz-Menger J. et al . Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009; 53 1475-1487
- 26 Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999; 99 1091-1100
- 27 Calabrese F, Basso C, Carturan E. et al . Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses?. Cardiovasc Pathol. 2006; 15 11-17
- 28 Fabre A, Sheppard M N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart. 2006; 92 316-320
- 29 Sen-Chowdhry S, Syrris P, Ward D. et al . Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007; 115 1710-1720
- 30 Awad M M, Calkins H, Judge D P. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008; 5 258-267
- 31 McKenna W J, Thiene G, Nava A. et al . Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994; 71 215-218
- 32 Midiri M, Finazzo M, Brancato M. et al . Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol. 1997; 7 307-312
- 33 Tandri H, Macedo R, Calkins H. et al . Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J. 2008; 155 147-153
- 34 Sen-Chowdhry S, Prasad S K, Syrris P. et al . Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol. 2006; 48 2132-2140
- 35 Maceira A M, Joshi J, Prasad S K. CMR in Amyloidosis. Circulation. 2005; 111 186-193
- 36 Vignaux O, Dhote R, Duboc D. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr. 2002; 26(5) 762-767
- 37 Patel M R, Cawely P J, Heitner J F. Improved diagnostic sensitivity of contrast enhanced cardiac MRI for cardiac sarcoidosis. (Abstract). Circulation. 2004; 108 (Suppl.) 645
- 38 Kolnagou A, Michaelides Y, Kontos C. et al . Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone. Hemoglobin. 2008; 32 17-28
- 39 Pennell D J. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci. 2005; 1054 373-378
- 40 Tanner M A, Galanello R, Dessi C. et al . A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007; 115 1876-1884
- 41 Pilgrim T M, Wyss T R. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: A systematic review. Int J Cardiol. 2008; 124 283-292
- 42 Bybee K A, Kara T, Prasad A. et al . Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004; 141 858-865
- 43 Rolf A, Nef H M, Möllmann H. et al . Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J. 2009; 30 1635-1642
- 44 Sutton R, Kanal E, Wilkoff B L. et al . Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design. Trials. 2008; 9 68
Dr. med. Peter Bernhardt
Universitätsklinikum Ulm
Klinik für Innere Medizin II
Albert-Einstein-Allee 23
89081 Ulm
eMail: peter.bernhardt@uniklinik-ulm.de